This Year 2017 in Aperplexing World

Total Page:16

File Type:pdf, Size:1020Kb

This Year 2017 in Aperplexing World sph this year 2017 in a perplexing world. in aperplexing THOUGHT “ Our core purpose commits us to redouble our eort to ensure that we narrow these divides to produce the science and scholarship that contributes to a better, healthier world for all.” DEAR COLLEAGUES: WELCOME TO SPH THIS YEAR, our School’s us to always ask what the role of public health is in annual report. these changing times. To that end, while in this issue Our School’s core purpose is “Think. Teach. Do. of SPH This Year we feature the work of the School, For the health of all.” This aims to describe and we also feature 23 deans and program directors of animate what we do: we generate ideas through our other schools and programs talking about the role scholarship and research, think; we transmit this of public health in these times—their comments knowledge to the next generation, teach; and we work are captured on pages 46 to 49 of this issue and on to communicate these ideas and be a part of the the web at bu.edu/sph/thisyear17—who create a action that contributes to a healthier world, do. This compelling portrait of the central role that academic issue of SPH This Year focuses on our scholarship at public health stands to play in the years ahead. Thank a time when thought and science have become more you to all of our colleagues who participated in these important than ever. interviews; we learned from all your comments and Over the past year, we have seen the country— are excited to work together in the coming years. and to some extent, the world—engage in debate and I hope that all readers of SPH This Year enjoy this discussion that challenge the foundations on which summary of our work. A hard-earned thank-you goes the health of the public is built. We have seen e­orts to the communications group responsible for pro- to push back on gains around global environmental ducing SPH This Year. As important, a thank-you to climate change, gender equity, and social and eco- all members of our community, including the faculty, nomic justice. This creates a dangerous world, one sta­, students, alumni, and friends of the School— that has experienced repeated natural disasters and some of whom are featured in this SPH This Year, but the US’s deadliest-ever mass shooting, and one that many more who are not—who make this a dynamic, threatens to erode hard-fought gains in the health forward-looking School, deeply committed to promot- of populations. These shifts are, indeed, in many ing the health of populations. ways perplexing. But they also speak to some of the fundamental divides that color our world. Our core Warm regards, purpose commits us to redouble our e­ort to ensure that we narrow these divides to produce the science and scholarship that contributes to a better, healthier Sandro Galea, MD, DrPH world for all. Dean, Robert A. Knox Professor The cover, a Rorschach blot comprised of hundreds Twitter: @sandrogalea of images reflecting some of the most important public health themes that rose to prominence over the past year, challenges us to ask what we see in these pictures, what we see overall, and where these narratives lead us. Most importantly, it challenges COVER ILLUSTRATION CHARIS TSEVIS, KHENG GUAN TOH/HEMERA/GETTY IMAGES; LEFT ERIC LEVIN IMAGES; TOH/HEMERA/GETTY KHENG GUAN CHARIS TSEVIS, ILLUSTRATION COVER contents FEATURES SPECIAL FEATURE THERE’S SOMETHING IN THE AIR: PCBs. New Bedford Harbor is polluting 12 the city’s air. WHY ARE OUR MOTHERS DYING? Maternal mortality 22 rates are up in the US. NO EASY Rx FOR POOR PHARMACEUTICAL ACCESS. Getting essential medicines to those who need them. HOW WE SEE IT. 30 Public health professionals from across the US discuss today’s challenges. UPENDING THE GUN DEBATE. YOUR MONEY OR YOUR LIFE. Shifting the gun Preventing a 21st-century health-poverty trap. debate from control 46 4 34 to safety. SMALL BLOOD FACULTY SPOTLIGHT DEAN’S NOTE SAMPLES YIELD BIG CLUES ON LONGEVITY. IS JUSTICE CRUCIAL Biomarkers predict TO HEALTH? aging and its related eff ects. Shared justice can improve 40 56 public health. WEIGHT HISTORY 18 SIGNATURE EVENTS CAN TIP SCALES OF HEALTH RISK. PROFESSOR RECEIVES Extra weight at PRESTIGIOUS BU TEACHING AWARD. 32 SPH BY THE NUMBERS any time in life increases risk. Sophie Godley honored for 60 FACULTY PUBLICATIONS 52 inspiring students. COVER ILLUSTRATION CHARIS TSEVIS, KHENG GUAN TOH/HEMERA/GETTY IMAGES; LEFT AP IMAGES; RIGHT TOP TO BOTTOM CARL PEER; JOSE LUIS LUIS PEER; JOSE CARL BOTTOM TO RIGHT TOP LEFT AP IMAGES; IMAGES; TOH/HEMERA/GETTY KHENG GUAN CHARIS TSEVIS, ILLUSTRATION COVER IMAGES EMESILVA/GETTY IMAGES; ROMANELLI/GETTY MARC REX/SHUTTERSTOCK; IMAGES; NURPHOTO/GETTY IMAGES; PELAEZ INC/GETTY NEWS IMAGES SPENCER PLATT/GETTY SCOTT; RIGHT CYDNEY LEFT TO BOTTOM IMAGES; TOH/HEMERA/GETTY KHENG GUAN CHARIS TSEVIS, TOP 50 feature BROAD INITIATIVES ARE NEEDED TO ADDRESS GROWING INEQUITIES AND PREVENT A 21ST-CENTURY YOUR HEALTH-POVERTY TRAP. MONEY OR YOUR THE SURVIVAL GAP between the richest and poor- est Americans is widening, with the richest 1 per- cent living 10 to 15 years longer than the poorest 1 percent, feeding the country’s growing health inequities, according to School of Public Health LIFEresearchers writing in a special series in. The Lancet. AP IMAGES feature BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH | SPH THIS YEAR 2017 | 7 THE LITERATURE POINTS OVER “WHELMINGLY TO THE FACT THAT SOCIOECONOMIC Based on current trends, the gap in life expectancy between the poorest 20 percent and wealthiest 20 percent of Americans is projected to increase by nearly a decade in a single HEALTH generation—rising from 77 versus 82 years for Americans born in 1930, to 76 versus 89 years for those born in 1960. GAPS “We are witnessing a slow-moving disaster unfolding for the health of lower-income Americans ARE WIDENING who entered the labor force after the postwar boom and have spent their working lives in a period IN THE UNITED of rising income inequalities,” Bor said. “Rising economic insecurity among poor and middle-class STATES. THIS CONSENSUS Americans has led to the persistence of smoking and the rise of obesity and opioid epidemics, IS NOTABLE with adverse consequences for health and life expectancy. At the same time, paying for healthcare GIVEN CURRENT in the USA today can bankrupt households and impoverish families.” EFFORTS TO SPH researchers say that behind changes in individual risk factors, such as smoking, obesity, CUT SAFETY NET and substance use, lie “distal factors” fueling the growth of survival inequities, such as unequal PROGRAMS access to technological innovations, increased geographic segregation by income, reduced eco- THAT PROTECT nomic mobility, and increased exposure to the high costs of medical care. THE HEALTH OF They recommend further research into socioeconomic inequalities in illness, rather than THE POOR.” JACOB BOR, just mortality: “Without interventions to decouple income and health or to reduce inequalities in ASSISTANT PROFESSOR OF GLOBAL HEALTH income, we might see the emergence of a 21st-century health-poverty trap and the further widen- ing and hardening of socioeconomic inequalities in health.” “The rise in income inequality in the USA in 1980–2015 has coincided with widening THE RICHEST 1% LIVE inequalities in health and longevity. Not only do the poor have lower incomes, they increasingly live shorter lives than do higher-income Americans,” writes Jacob Bor, assistant professor of global health; Sandro Galea, dean and Robert A. Knox Professor; and Gregory Cohen, statistical analyst in epidemiology. The five-paper Lancet series highlights the need for broad initiatives to address struc- tural racism and inequality and health reform that moves toward a single-payer system 10–15 to address growing health inequities and prevent a 21st-century health-poverty trap. The SPH team reviewed studies assessing changes in survival gaps between Ameri- cans of di­erent socioeconomic strata since 1980. “The literature points overwhelmingly to the fact that socioeconomic health gaps YEARS are widening in the United States,” Bor said. “This consensus is notable given current e­orts to cut safety net programs that protect the health of the poor.” LONGER THAN THE The researchers noted that, since 2001, the poorest 5 percent of Americans have POOREST 1% experienced no gains in survival, while middle- and high-income Americans have seen their life expectancy increase by two years. The researchers identified two distinct trends from 2001 to 2014: poverty deepened, and poverty became an increasingly important risk factor for poor health. PETER ESSICK/ GETTY IMAGES PETER ESSICK/ research BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH | SPH THIS YEAR 2017 | 9 % Police-Led Addiction 95 Program in Gloucester OF THOSE OFFERED Shows First-Year PLACEMENTS ENTERED THEIR ASSIGNED Success PROGRAM. ACCORDING TO A REPORT by SPH researchers published in the New England Journal of Medicine, during the first year of a widely publicized initiative aimed at combatting the opioid epidemic, about 95 percent of individuals with substance-use disorders who came to the Gloucester Police Department for help accessing addiction treatment were placed in detoxifica- tion or substance-use treatment programs. The authors cred- ited a number of factors for the program’s success, including participants motivated to enter treatment, police working to find placements and establish a relationship with a local treatment center, and state-mandated insurance covering drug detoxification. In June 2015, the Gloucester Police Department began the initiative—dubbed the Angel Program—that encourages those with opioid use disorders to come to the department and ask for treatment help, with no threat of arrest.
Recommended publications
  • LINKING INFECTIOUS and NARCOLOGY CARE) Evidence-Based for Engagement in HIV Care
    COMPENDIUM OF EVIDENCE-BASED INTERVENTIONS AND BEST PRACTICES FOR HIV PREVENTION LINC (LINKING INFECTIOUS AND NARCOLOGY CARE) Evidence-Based for Engagement in HIV Care INTERVENTION DESCRIPTION Goal of Intervention • Improve engagement in HIV care • Improve retention in HIV care • Improve CD4+ cell count • Reduce self-reported hospitalizations Target Population • HIV-positive injecting drug users in treatment Brief Description LINC (Linking Infectious and Narcology Care) is an individual-level, strengths-based case management intervention for HIV-positive persons who inject drugs (PWID). It is adapted from the Antiretroviral Treatment Access Study (ARTAS). LINC involves coordination between the HIV and narcology systems of care to reduce barriers to HIV care and help motivate HIV-positive PWID to engage in care by supporting recognition of one’s strengths to make positive life changes. The initial session is delivered in a narcology hospital (e.g., in-patient addiction treatment setting) and includes provision of CD4 test results to increase engagement in HIV medical care. After discharge, subsequent sessions are conducted in community or clinic locations over six months. LINC aims to build self-efficacy, enable self-management, and increase outcome expectancies regarding engaging in HIV care via education and social support. Theoretical Basis • Social Cognitive Theory (SCT) • Psychological Empowerment Theory (PET) Intervention Duration • Five sessions delivered over six months Intervention Settings • Narcology hospital • Community or clinic locations • Phone Deliverer • Peer case managers (i.e., HIV-infected men and women in recovery from addiction) LRC Chapter – LINC (Linking Infectious and Narcology Care) Last updated March 17, 2020 COMPENDIUM OF EVIDENCE-BASED INTERVENTIONS AND BEST PRACTICES FOR HIV PREVENTION Delivery Methods • Case management • Printed materials • Discussion • Video • Goal setting Structural Components There are no reported structural components reported for this study.
    [Show full text]
  • Summary Analgesics Dec2019
    Status as of December 31, 2019 UPDATE STATUS: N = New, A = Advanced, C = Changed, S = Same (No Change), D = Discontinued Update Emerging treatments for acute and chronic pain Development Status, Route, Contact information Status Agent Description / Mechanism of Opioid Function / Target Indication / Other Comments Sponsor / Originator Status Route URL Action (Y/No) 2019 UPDATES / CONTINUING PRODUCTS FROM 2018 Small molecule, inhibition of 1% diacerein TWi Biotechnology / caspase-1, block activation of 1 (AC-203 / caspase-1 inhibitor Inherited Epidermolysis Bullosa Castle Creek Phase 2 No Topical www.twibiotech.com NLRP3 inflamasomes; reduced CCP-020) Pharmaceuticals IL-1beta and IL-18 Small molecule; topical NSAID Frontier 2 AB001 NSAID formulation (nondisclosed active Chronic low back pain Phase 2 No Topical www.frontierbiotech.com/en/products/1.html Biotechnologies ingredient) Small molecule; oral uricosuric / anti-inflammatory agent + febuxostat (xanthine oxidase Gout in patients taking urate- Uricosuric + 3 AC-201 CR inhibitor); inhibition of NLRP3 lowering therapy; Gout; TWi Biotechnology Phase 2 No Oral www.twibiotech.com/rAndD_11 xanthine oxidase inflammasome assembly, reduced Epidermolysis Bullosa Simplex (EBS) production of caspase-1 and cytokine IL-1Beta www.arraybiopharma.com/our-science/our-pipeline AK-1830 Small molecule; tropomyosin Array BioPharma / 4 TrkA Pain, inflammation Phase 1 No Oral www.asahi- A (ARRY-954) receptor kinase A (TrkA) inhibitor Asahi Kasei Pharma kasei.co.jp/asahi/en/news/2016/e160401_2.html www.neurosmedical.com/clinical-research;
    [Show full text]
  • Boletin De Documentación Nº 37, Marzo De 2009
    Su elaboración en formato electrónico, iniciada en julio de 2002, ha supuesto importantes ventajas de cara a ampliar y agilizar su difusión entre los profesionales del sector, permitiendo asimismo la localización de documentación relevante por parte de cualquier ciudadano interesado en el campo de las drogodependencias. Como en los números anteriores, en el boletín de marzo se recogen las principales novedades bibliográficas que, sobre los distintos aspectos relacionados con las adicciones, han tenido entrada en el Centro de Documentación e Información de la Delegación del Gobierno para el Plan Nacional sobre Drogas en los tres últimos meses. El contenido del Boletín está estructurado en tres grandes epígrafes: Novedades bibliográficas (clasificadas por su temática y con indicación de su ruta en el caso de que estén disponibles a texto completo en Internet), Legislación y Sumarios de revistas. Esperamos que el Boletín, cuya difusión se realiza a través de listas de distribución de correo electrónico y de su presencia permanente en la página web de la Delegación del Gobierno para el Plan Nacional sobre Drogas, sea de interés y quedamos a la espera de cualquier sugerencia y/o consulta que sobre el mismo queráis formular. Ministerio de Sanidad y Consumo. Delegación del Gobierno para el Plan Nacional sobre Drogas José del Val – E-correo: [email protected] Jefe de Servicio del Centro de Documentación e Información 1 Aspectos Generales ........................................................................ 4 Aspectos Sociales ............................................................................
    [Show full text]
  • Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
    CLASSIFICATION DECISIONS TAKEN BY THE HARMONIZED SYSTEM COMMITTEE FROM THE 47TH TO 60TH SESSIONS (2011 - 2018) WORLD CUSTOMS ORGANIZATION Rue du Marché 30 B-1210 Brussels Belgium November 2011 Copyright © 2011 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to [email protected]. D/2011/0448/25 The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee ( 47th Session – March 2011) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale. Advice Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be. HS codes Classification No Product description Classification considered rationale 1. Preparation, in the form of a powder, consisting of 92 % sugar, 6 % 2106.90 GRIs 1 and 6 black currant powder, anticaking agent, citric acid and black currant flavouring, put up for retail sale in 32-gram sachets, intended to be consumed as a beverage after mixing with hot water. 2. Vanutide cridificar (INN List 100). 3002.20 3. Certain INN products. Chapters 28, 29 (See “INN List 101” at the end of this publication.) and 30 4. Certain INN products. Chapters 13, 29 (See “INN List 102” at the end of this publication.) and 30 5. Certain INN products. Chapters 28, 29, (See “INN List 103” at the end of this publication.) 30, 35 and 39 6. Re-classification of INN products.
    [Show full text]
  • Use of the Communication Checklist
    Psychiatria Danubina, 2020; Vol. 32, Suppl. 1, pp 88-92 Conference paper © Medicinska naklada - Zagreb, Croatia USE OF THE COMMUNICATION CHECKLIST - SELF REPORT (CC-SR) IN SCHIZOPHRENIA: LANGUAGE IMPAIRMENTS CORRELATE WITH POOR PREMORBID SOCIAL ADJUSTMENT Daria Smirnova1,2, Svetlana Zhukova3, Olga Izmailova4, Ilya Fedotov5, Yurii Osadshiy6, Alexander Shustov7, Anna Spikina8, Dmitriy Ubeikon9, Anna Yashikhina2, Natalia Petrova10, Johanna Badcock1, Vera Morgan1 & Assen Jablensky1 1Centre for Clinical Research in Neuropsychiatry, University of Western Australia, Perth, Australia 2Department of Psychiatry, Narcology, Psychotherapy and Clinical Psychology, Samara State Medical University, Samara, Russia 3Department of Psychiatry, Narcology and Psychology, Ivanovo State Medical Academy, Ivanovo, Russia 4Samara District Clinical Psychiatric Hospital, Samara, Russia 5Department of Psychiatry, Ryazan State Medical University n.a. academician I.P. Pavlov, Ryazan, Russia 6Department of Psychiatry, Narcology and Medical Psychology, Rostov State Medical University, Rostov-on-Don, Russia 7National Medical Research Centre of Psychiatry and Narcology n.a. V.P. Serbsky, Moscow, Russia 8Psychoneurological dispensary ʋ2, Saint Petersburg, Russia 9Department of Psychiatry, Narcology and Psychotherapy with the course of General and Medical psychology, S.I. Georgievsky Medical Academy, V.I. Vernadsky Crimean Federal University, Simferopol, Republic of Crimea, Russia 10Department of Psychiatry and Narcology, Saint Petersburg State University, Saint Petersburg,
    [Show full text]
  • Workbook Psychiatry and Narcology
    Kharkiv National Medical University Department of Psychiatry, Narcology and Medical Psychology WORKBOOK MANUAL FOR INDIVIDUAL WORK FOR MEDICAL STUDENTS PSYCHIATRY AND NARCOLOGY (Part 2) Student ___________________________________________________________ Faculty _________________________________________________________ Course _________________ Group _____________________________________ Kharkiv 2019 Затверджено вченою радою ХНМУ Протокол №5 від 23.05.2019 р. Psychiatry (Part 2) : workbook manual for individual work of students / I. Strelnikova, G. Samardacova, К. Zelenska – Kharkiv, 2019. – 103 p. Копіювання для розповсюдження в будь-якому вигляді частин або повністю можливо тільки з дозволу авторів навчального посібника. CLASS 7. NEUROTIC DISORDERS. CLINICAL FORMS. TREATMENT AND REHABILITATION. POSTTRAUMATIC STRESS DISORDER. TREATMENT AND REHABILITATION. Psychogenic diseases are a large and clinically varied group of diseases resulting from an effect of acute or long-term psychic traumas, which manifest themselves by both mental and somatoneurological disorders and, as a rule, are reversible. Psychogenic diseases are caused by a psychic trauma, i.e. some events which affect significant aspects of existence of the human being and result in deep psychological feelings. These may be subjectively significant events, i.e. those which are pathogenic for the majority of people. Besides, the psyche may be traumatized by conventionally pathogenic events, which cause feelings in an individual because of his peculiar hierarchy of values. Unfavorable psychogenic effects on the human being cause stress in him, i.e. a nonspecific reaction at the physiological, psychological and behavioural levels. Stress may exert some positive, mobilizing influence, but may result in disorganization of the organism activity. The stress, which exerts a negative influence and causes various disturbances and even diseases, is termed distress. Classification of neurotic disorders I.
    [Show full text]
  • Young Psychiatrists' Network Meeting “Stigma from the Yps' Perspective: Hopes and Challenges”, September 27-29 2012, Minsk, Belarus
    International conference 3rd Young Psychiatrists’ Network Meeting “Stigma From The YPs' perspective: Hopes and Challenges” September 27-29, 2012 Programme and abstract booklet Ministry of Health of the Republic Of Belarus State Educational Establishment “Belarusian Medical Academy of Post-Graduate Education” Supported by Rotary club “Minsk” International conference 3rd Young Psychiatrists’ Network Meeting “Stigma From The YPs' perspective: Hopes and Challenges” September 27-29, 2012 Programme and abstract booklet Ltd “Magic” Minsk 2012 UDC (УДК) 61 LCN (ББК) 56.14 Scientific edition 3rd Young Psychiatrists' Network Meeting “Stigma From The YPs' perspective: Hopes and Challenges”, September 27-29 2012, Minsk, Belarus. International conference: Programme and abstract booklet. – Minsk: Publishing house “Magic“, 2012. - 84 p. ISBN 978 – 985-6473-81-7 Supported by European Federation of Psychiatrists’ Trainees (EFPT) Supported by Belarusian Medical Academy of Post-Graduate Education (BelMAPGE) Supported by Belarusian Psychiatric Association (BPA) Supported by Rotary club “Minsk” Editorial Board: J. Hanson, MD, PhD, Assoc. Prof., Sweden; D. Krupchanka, MD, PhD student, Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; N. Bezborodovs, MD, Riga Stradins University, Riga Centre of Psychiatry and Addiction Disorders, Latvia; M. Bendix, MD, Dr. Med., Karolinska University Hospital Huddinge, Sweden; S. Jauhar, MD, MBChB, BSc (Hons), MRCPsych, Department of Psychosis Studies, Institute of Psychiatry, United Kingdom; D. Smirnova, MD, PhD, Samara State Medical University, Russian Federation. ISBN 978 – 985-6473-81-7 © State Educational Establishment “Belarusian Medical Academy of Post- Graduate Education” Anyone who keeps learning stays young. The greatest thing in life is to keep your mind young. (c) There is a story of our meetings.
    [Show full text]
  • Bioethical Differences Between Drug Addiction Treatment Professionals Inside and Outside the Russian Federation Mendelevich
    Bioethical differences between drug addiction treatment professionals inside and outside the Russian Federation Mendelevich Mendelevich Harm Reduction Journal 2011, 8:15 http://www.harmreductionjournal.com/content/8/1/15 (10 June 2011) Mendelevich Harm Reduction Journal 2011, 8:15 http://www.harmreductionjournal.com/content/8/1/15 RESEARCH Open Access Bioethical differences between drug addiction treatment professionals inside and outside the Russian Federation Vladimir D Mendelevich Abstract This article provides an overview of a sociological study of the views of 338 drug addiction treatment professionals. A comparison is drawn between the bioethical approaches of Russian and foreign experts from 18 countries. It is concluded that the bioethical priorities of Russian and foreign experts differ significantly. Differences involve attitudes toward confidentiality, informed consent, compulsory treatment, opioid agonist therapy, mandatory testing of students for psychoactive substances, the prevention of mental patients from having children, harm reduction programs (needle and syringe exchange), euthanasia, and abortion. It is proposed that the cardinal dissimilarity between models for providing drug treatment in the Russian Federation versus the majority of the countries of the world stems from differing bioethical attitudes among drug addiction treatment experts. Introduction deontological norms [6,10]. Although there have been Russian and international narcology (addiction medi- calls for adherence to the principles of medical ethics, cine) began to develop along divergent paths during the the procedures put into practicecontinuetobeincom- second half of the twentieth century. Indeed, Russian patible with these principles. Drug addicts still have narcology has ceased to be a part of international nar- even fewer patient rights than the mentally ill.
    [Show full text]
  • Exam Questions Year 5 Psychiatry and Narcology General Medicine Faculty BSMU (2019/2020)
    Exam questions Year 5 Psychiatry and narcology General medicine faculty BSMU (2019/2020) Part 1 1. Object and task of psychiatry and narcology, their place among other medical disciplines. 2. History of psychiatry: middle ages, 19th century, modern psychiatry. 3. Stigma of mental Illness. Central anti-psychiatry beliefs. 4. Frame of psychiatry: general psychopathology, age psychiatry, organizational psychiatry, judicial, psychopharmacotherapy, addictology (narcology), trans-cultural psychiatry, sexology, suicidology. 5. The methods of investigations in psychiatry. 6. The criteria of mental health. Criteria of normality (Rosenhan and Seligman, 1984). 7. Biases that affect diagnoses: racial/ethnic, confirmation bias, institutionalization, reporting bias, cultural differences. 8. Classification in psychiatry, the most important classification categories. 9. Organic and functional disorders in psychiatry. Concepts of neurosis and psychosis. 10. Epidemiology of mental disorders. Prevalence of major psychiatric conditions. 11. Psychiatry examination. 12. Disturbances of perception: hallucinations, types of hallucinations. Pseudo-hallucinations. Circumstances and disorders associated with hallucinations. 13. Disturbances of perception: illusions, types of illusions. 14. Psycho-sensorial disturbances of perception: derealisation, dismorphophobia, methamorphopsias, and depersonalisation. 15. Disorders of mood (emotions): pathological affect, depression, mania, anhedonia, flattened affect, euphoria, emotional lability, inappropriate affect, phobias.
    [Show full text]
  • NGO Directory
    National Foundation for Health Progress and Research Development Centre Culturel d'Hussein-Day Africa 16000 Alger Algeria Phone: (213-21)2 31 655 Fax: (213-21) 23 1644 E-mail: [email protected] Contact: Mostefa KHIATI Title: President Founded in: 1990 ECOSOC : Special consultative status Drug Control Activities and Methods of Intervention: Prevention, education, counselling, research, training Repeated awareness raising campaigns Other Areas: Health, prevention of HIV/AIDS, solidarity, training National Foundation for Medical Research Cultural Centre of El-Biar Room 36 Africa El Biar, Algiers Algeria Phone: (213-2) 502 991 Fax: (213-2) 503 675 E-mail: Contact: Prof. Mustapha ACHOUI Title: President Founded in: 1980 ECOSOC : None Drug Control Activities and Methods of Intervention: Prevention, research and rehabilitation of drug abusers. Training of psychologists in prevention and rehabilitation techniques. Organizing and developing training systems. Target groups contacted with a few monographs. Other Areas: Research on various different medical cases. Page: 1 Movimento Nacional Vida Livre M.N.V.L. Av. Comandante Valodia No. 283, 2. And.P.24. Africa C.P. 3969 Angola, Rep. Of Luanda Phone: (244-2) 443 887 Fax: E-mail: Contact: Dr. Celestino Samuel Miezi Title: National Director, Professor Founded in: 1989 ECOSOC : Drug Control Activities and Methods of Intervention: Prevention, education, treatment, counselling, rehabilitation, training, and criminology To combat drugs and its consequences through specialized psychotherapy and detoxification Other Areas: Health, psychotherapy, ergo therapy Maison Blanche (CERMA) 03 BP 1718 Africa Cotonou Benin Phone: (229) 300850/302816 Fax: (229) 30 04 26 E-mail: Contact: Prof. Rene Gilbert AHYI Title: President Founded in: 1988 ECOSOC : None Drug Control Activities and Methods of Intervention: Prevention, treatment, training and education.
    [Show full text]
  • Perspektive 2023
    Perspektive 2023 Neue Medikamente in Entwicklung Inhalt 2 Neue Medikamente in Sicht 6 Neue Wege 8 Neue Chancen für Krebspatienten 10 Entzündungen zum Erliegen bringen 13 Infektionen bekämpfen 14 Gegen Krankheiten unterschiedlichster Art 16 Kindermedikamente und Orphan Drugs 19 Medikamente für Männer und Frauen 20 Die neuen Wirkstoffe 23 Der Beitrag Deutschlands 26 Projekte, die bis 2023 zu einer Zulassung führen können 44 Schwerpunkte der vfa-Mitglieder 46 Kontakt Blick voraus Mehr als zehn Jahre dauert es von der Idee bis zur Zulassung, manch- mal mehr als zwanzig. Erfolge mit neuen Medikamenten kann also nur ernten, wer lange vorher gesät hat. Das haben die forschenden Pharma-Unternehmen des vfa in den späten 2000er- und frühen 2010er-Jahren reichlich getan, so dass nun besonders viele Medika- mente in ihrer Erprobung weit fort geschritten sind. Welche es noch vor Ende 2023 bis zu einer Zulassung oder Zulassungserweiterung schaffen könnten, zeigt diese Veröffentlichung. Sie macht deutlich, dass zahlreiche Patientinnen und Patienten gute Aussichten auf bessere Behandlungsmöglich keiten für ihre Leiden haben. vfa – die forschenden Pharma-Unternehmen Perspektive 2023 Neue Medikamente in Sicht Viele Krankheiten sind in den letzten Jahren besser behandelbar geworden, und Patienten und Ärzte hoffen, dass dieser Strom des Fortschritts nicht abreißt. Die Chancen dafür stehen gut. Denn forschende Pharma-Unternehmen entwickeln derzeit gegen mehr als 145 Krankheiten Medikamente, die bis spätestens Ende 2023 die Zulassung erhalten könnten. Das zeigt eine Erhebung des vfa bei seinen Mitgliedsunter nehmen vom Oktober 2019. Demnach könnten bis Ende 2023 insgesamt 434 Sämtliche Projekte, die in der Erhebung erfasst ihrer Projekte zu einer Zulassung oder Zulassungs- wurden, sind ab S.
    [Show full text]
  • DMM Model of Osteoarthritis
    WHY DOES MY JOINT HURT: UNDERSTANDING DISEASE PHENOTYPE AND PAIN RELATIONSHIPS USING MOUSE MODELS OF ARTHRITIS Sanaa Zaki A thesis submitted in fulfilment of requirements for the degree of Doctor of Philosophy Faculty of Medicine (Sydney Medical School) The University of Sydney November 2016 i PREFACE The research embodied in this thesis was conducted at the Raymond Purves Laboratories of Bone and Joint Research, Kolling Institute of Medical Research, University of Sydney at the Royal North Shore Hospital, St Leonards, Australia. Institutional ethics committee approval was sought and obtained prior to the commencement of all animal experiments. The research was partly funded by Arthritis Australia. I certify that the intellectual content of this thesis is the product of my own work, including the design, conduct and analysis of experiments presented in this thesis. Contributions of other researchers and all the assistance received in preparing this thesis and relevant sources have been acknowledged. This thesis has not been submitted for any degree or other purpose. Sanaa Zaki ii ACKNOWLEDGEMENTS My PhD candidature has been a very long journey and I have many colleagues, friends and family that I need to acknowledge for their contribution. Firstly, I am forever indebted to the support and mentorship of my two supervisors, Mark Connor and Chris Little. They graciously bestowed me with the freedom to pave my own path of scientific discovery, while always being there to guide and redirect me when I needed it the most. I am truly indebted to their academic brilliance, scientific rigor and boundless patience. They are truly inspirational researchers that I can only hope to, one day, emulate.
    [Show full text]